HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Shiseido to sell Zirh

This article was originally published in The Rose Sheet

Executive Summary

Japanese beauty company has entered into an agreement to sell Zirh men's skin-care and fragrance brand and Corduroy men's fragrance brand to a group of private investors led by former Zirh president Brian Robinson, who resigned in 2005 (1"The Rose Sheet" Jan. 3, 2005, In Brief). Zirh International Corp., which markets the affected brands, will be renamed ZIC Corp. and continue to function as a wholly owned Shiseido subsidiary, allowing the company "to focus [its] strengths and invest business resources in the John Varvatos brand and [its] Shiseido Men skin-care line," according to Shuichi Tanaka, chairman and CEO, Shiseido International Corporation. "Brian Robinson has unique experience in the men's skin-care market as well as an intimate working knowledge of the Zirh brand. This transaction will provide the Zirh and Corduroy brands with a business structure better suited for their growth and expansion"...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014951

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel